INCY News and Press, Incyte Corporation From 05/31/24

2024-05-31 21:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Acquisition strengthens Incyte’s Inflammation and Autoimmunity (IAI) pipeline and reinforces commitment to bring innovative solutions to patients Incyte (Nasdaq:INCY) today announced that it has completed its acquisition of Escient Pharmaceuticals, a clinical-stage drug discovery...

2024-05-23 12:43:05 ET More on Incyte Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade) Incyte jumps 6%, intends to buy back $2B stock Incyte Non-GAAP EPS of $0.64 misses by $0.19, revenue of $880.89M misses by $43.75M Incyte Corporation (INCY) Q1 202...

2024-05-23 08:00:10 ET James Shin from Deutsche Bank issued a price target of $55.00 for INCY on 2024-05-23 06:54:00. The adjusted price target was set to $55.00. At the time of the announcement, INCY was trading at $58.2. The overall price target consensus is at $85.64 ...

Incyte (Nasdaq:INCY) today announced the expansion of its presence in Delaware with the acquisition of two buildings at 1100 North King Street and 1100 North French Street in downtown Wilmington. This acquisition marks Incyte’s fourth expansion in Delaware since establishing operations in ...

Incyte (Nasdaq: INCY) today announced that several abstracts featuring data from its oncology portfolio will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held May 31 – June 4 in Chicago, and at the European Hematology Association 2024 (EHA20...

2024-05-13 08:04:18 ET More on Incyte Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade) Incyte Non-GAAP EPS of $0.64 misses by $0.19, revenue of $880.89M misses by $43.75M Incyte Q1 2024 Earnings Preview Read the full article on Seeking Alpha ...

Incyte commences Dutch Auction tender offer to repurchase up to $1.67 billion of outstanding common shares Incyte Corporation (Nasdaq:INCY) (the “Company”) today announced that its Board of Directors approved a share repurchase authorization of $2.0 billion. The Compan...

2024-05-09 06:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We live in the best of times where life is not capped at 45 or 50 years of age, all thanks to wonderful discoveries in the field of biotechnology. The resources being invested to produce new dr...

2024-05-02 04:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...